Comparison of bromfenac 0.09% QD to nepafenac 0.1% TID after cataract surgery: pilot evaluation of visual acuity, macular volume, and retinal thickness at a single site

PURPOSE: The purpose of this study was to investigate the clinical outcomes of bromfenac ophthalmic solution 0.09% once daily (QD) and nepafenac 0.1% ophthalmic suspension three times daily following cataract extraction with posterior chamber intraocular lens implantation, specifically looking at an...

Descripción completa

Detalles Bibliográficos
Autor principal: Cable, Melissa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2012
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3399390/
https://www.ncbi.nlm.nih.gov/pubmed/22815642
http://dx.doi.org/10.2147/OPTH.S32179

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3399390/
https://www.ncbi.nlm.nih.gov/pubmed/22815642
http://dx.doi.org/10.2147/OPTH.S32179

Ejemplares similares